227 related articles for article (PubMed ID: 19620296)
1. Leukotriene B4 potentiates CpG signaling for enhanced cytokine secretion by human leukocytes.
Gaudreault E; Gosselin J
J Immunol; 2009 Aug; 183(4):2650-8. PubMed ID: 19620296
[TBL] [Abstract][Full Text] [Related]
2. TAK1 contributes to the enhanced responsiveness of LTB(4)-treated neutrophils to Toll-like receptor ligands.
Gaudreault É; Paquet-Bouchard C; Fiola S; Le Bel M; Lacerte P; Shio MT; Olivier M; Gosselin J
Int Immunol; 2012 Nov; 24(11):693-704. PubMed ID: 22843747
[TBL] [Abstract][Full Text] [Related]
3. [Toll-like receptor 9 in cpG oligodeoxynucleotides-induced species-specific immune responses].
Li N; Fan XG; Tang SE; Zhu C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 30(5):533-5. PubMed ID: 16320582
[TBL] [Abstract][Full Text] [Related]
4. Activation of foal neutrophils at different ages by CpG oligodeoxynucleotides and Rhodococcus equi.
Liu M; Liu T; Bordin A; Nerren J; Cohen N
Cytokine; 2009 Dec; 48(3):280-9. PubMed ID: 19819162
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil recognition of bacterial DNA and Toll-like receptor 9-dependent and -independent regulation of neutrophil function.
El Kebir D; József L; Filep JG
Arch Immunol Ther Exp (Warsz); 2008; 56(1):41-53. PubMed ID: 18250968
[TBL] [Abstract][Full Text] [Related]
6. Bacterial DNA activates endothelial cells and promotes neutrophil adherence through TLR9 signaling.
El Kebir D; József L; Pan W; Wang L; Filep JG
J Immunol; 2009 Apr; 182(7):4386-94. PubMed ID: 19299739
[TBL] [Abstract][Full Text] [Related]
7. Bacterial DNA activates human neutrophils by a CpG-independent pathway.
Trevani AS; Chorny A; Salamone G; Vermeulen M; Gamberale R; Schettini J; Raiden S; Geffner J
Eur J Immunol; 2003 Nov; 33(11):3164-74. PubMed ID: 14579285
[TBL] [Abstract][Full Text] [Related]
8. TLR-9 activation aggravates concanavalin A-induced hepatitis via promoting accumulation and activation of liver CD4+ NKT cells.
Jiang W; Sun R; Zhou R; Wei H; Tian Z
J Immunol; 2009 Mar; 182(6):3768-74. PubMed ID: 19265155
[TBL] [Abstract][Full Text] [Related]
9. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
Brummel R; Roberts TL; Stacey KJ; Lenert P
Eur J Immunol; 2006 Jul; 36(7):1951-62. PubMed ID: 16791898
[TBL] [Abstract][Full Text] [Related]
10. The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity.
Sen G; Flora M; Chattopadhyay G; Klinman DM; Lees A; Mond JJ; Snapper CM
Cell Immunol; 2004; 232(1-2):64-74. PubMed ID: 15922717
[TBL] [Abstract][Full Text] [Related]
11. Non-CpG-containing antisense 2'-methoxyethyl oligonucleotides activate a proinflammatory response independent of Toll-like receptor 9 or myeloid differentiation factor 88.
Senn JJ; Burel S; Henry SP
J Pharmacol Exp Ther; 2005 Sep; 314(3):972-9. PubMed ID: 15919763
[TBL] [Abstract][Full Text] [Related]
12. CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion.
Sanjuan MA; Rao N; Lai KT; Gu Y; Sun S; Fuchs A; Fung-Leung WP; Colonna M; Karlsson L
J Cell Biol; 2006 Mar; 172(7):1057-68. PubMed ID: 16567503
[TBL] [Abstract][Full Text] [Related]
13. Synthetic methylated CpG ODNs are potent in vivo adjuvants when delivered in liposomal nanoparticles.
Chikh G; de Jong SD; Sekirov L; Raney SG; Kazem M; Wilson KD; Cullis PR; Dutz JP; Tam YK
Int Immunol; 2009 Jul; 21(7):757-67. PubMed ID: 19502586
[TBL] [Abstract][Full Text] [Related]
14. Alpha 2-macroglobulin binds CpG oligodeoxynucleotides and enhances their immunostimulatory properties by a receptor-dependent mechanism.
Anderson RB; Cianciolo GJ; Kennedy MN; Pizzo SV
J Leukoc Biol; 2008 Feb; 83(2):381-92. PubMed ID: 17967834
[TBL] [Abstract][Full Text] [Related]
15. Oral and intraperitoneal administration of phosphorothioate oligodeoxynucleotides leads to control of Cryptosporidium parvum infection in neonatal mice.
Barrier M; Lacroix-Lamandé S; Mancassola R; Auray G; Bernardet N; Chaussé AM; Uematsu S; Akira S; Laurent F
J Infect Dis; 2006 May; 193(10):1400-7. PubMed ID: 16619188
[TBL] [Abstract][Full Text] [Related]
16. Specific siRNA downregulated TLR9 and altered cytokine expression pattern in macrophage after CpG DNA stimulation.
Qiao B; Li B; Yang X; Zhang H; Chu Y; Wang Y; Xiong S
Cell Mol Immunol; 2005 Apr; 2(2):130-5. PubMed ID: 16191419
[TBL] [Abstract][Full Text] [Related]
17. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances anti-tumor responses of peripheral blood mononuclear cells from human lung cancer patients.
Ren T; Wen ZK; Liu ZM; Qian C; Liang YJ; Jin ML; Cai YY; Xu L
Cancer Invest; 2008 Jun; 26(5):448-55. PubMed ID: 18568766
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors.
El Andaloussi A; Sonabend AM; Han Y; Lesniak MS
Glia; 2006 Nov; 54(6):526-35. PubMed ID: 16906541
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
Ilvesaro JM; Merrell MA; Li L; Wakchoure S; Graves D; Brooks S; Rahko E; Jukkola-Vuorinen A; Vuopala KS; Harris KW; Selander KS
Mol Cancer Res; 2008 Oct; 6(10):1534-43. PubMed ID: 18922969
[TBL] [Abstract][Full Text] [Related]
20. Nucleosome-induced neutrophil activation occurs independently of TLR9 and endosomal acidification: implications for systemic lupus erythematosus.
Lindau D; Rönnefarth V; Erbacher A; Rammensee HG; Decker P
Eur J Immunol; 2011 Mar; 41(3):669-81. PubMed ID: 21287547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]